| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adma Biologics, Inc. (ADMA) has 9 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. ADMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.26M | $18.35M | - | |
| Dir | 2.05M | $16.61M | - | |
| Dir | 488.9K | $3.97M | - | |
| COO | 446.2K | $3.62M | - | |
| Dir | 263.0K | $2.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 21, 2019 | Perceptive Advisors LLC51 | 10% Owner | Buy | 4,000,000 | $4.00 | $16,000,000.00 | +53.2% | |
| May 17, 2019 | Grossman Adam S66 | President And CEO | Buy | 30,000 | $4.00 | $120,000.00 | +3.6% | |
| May 17, 2019 | Lenz Brian | EVP, CFO | Buy | 5,000 | $4.00 | $20,000.00 | +25.0% | |
| May 17, 2019 | Guiheen Lawrence P.70 | Director | Buy | 25,000 | $4.00 | $100,000.00 | +100.0% | |
| May 17, 2019 | Mond James | EVP, CSO And CMO | Buy | 4,500 | $4.00 | $18,000.00 | +33.6% | |
| May 17, 2019 | Grossman Jerrold B68 | Director | Buy | 12,000 | $4.00 | $48,000.00 | +12.2% | |
| Jun 8, 2018 | Grossman Jerrold B68 | Director | Buy | 52,302 | $4.78 | $250,003.56 | +67.8% | |
| Jun 8, 2018 | Richman Eric I79 | Director | Buy | 5,230 | $4.78 | $24,999.40 | +16.7% | |
| Jun 8, 2018 | Grossman Adam S66 | President And CEO | Buy | 73,222 | $4.78 | $350,001.16 | +9.7% | |
| Jun 8, 2018 | Lenz Brian | VP, CFO | Buy | 5,000 | $4.78 | $23,900.00 | +33.3% |